DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease

Neuroscience Letters

Volumn 461, Issue 2, 2009, Pages 74-75

  Keeling, Brett H ^a   Vilariño Güell, Carles ^a   Ross, Owen A ^a   Wszolek, Zbigniew K ^b   Uitti, Ryan J ^b   Farrer, Matthew J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

DRD3; Essential tremor; HS1BP3; Parkinson disease

Indexed keywords

BINDING PROTEIN; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR D3; HCLS1 BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; RECEPTORS, DOPAMINE D3; RISK FACTORS;

EID: 67649656094     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.05.084     Document Type: Article

References (21)

1. Benito-Leon J., and Louis E.D. Essential tremor: emerging views of a common disorder. Nat. Clin. Pract. Neurol. 2 (2006) 666-678 (quiz 662p following 691)
2. Benito-Leon J., Louis E.D., and Bermejo-Pareja F. Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J. Neurol. Neurosurg. Psychiatry 80 (2009) 423-425
3. Blair M.A., Ma S., Phibbs F., Fang J.Y., Cooper M.K., Davis T.L., and Hedera P. Reappraisal of the role of the DRD3 gene in essential tremor. Parkinsonism Relat. Disord. 14 (2008) 471-475
4. Deng H., Le W., Davidson A.L., Xie W., and Jankovic J. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor. Neurosci. Lett. 407 (2006) 97-100
5. Deng H., Le W., and Jankovic J. Genetics of essential tremor. Brain 130 (2007) 1456-1464
6. Deng H., Le W.D., Guo Y., Huang M.S., Xie W.J., and Jankovic J. Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology 65 (2005) 651-652
7. Higgins J.J., Lombardi R.Q., Pucilowska J., Jankovic J., Golbe L.I., and Verhagen L. HS1-BP3 gene variant is common in familial essential tremor. Mov. Disord. 21 (2006) 306-309
8. Higgins J.J., Lombardi R.Q., Pucilowska J., Jankovic J., Tan E.K., and Rooney J.P. A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology 64 (2005) 417-421
9. Jeanneteau F., Funalot B., Jankovic J., Deng H., Lagarde J.P., Lucotte G., and Sokoloff P. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 10753-10758
10. Liu Y.Z., Tang B.S., Yan X.X., Liu J., Ouyang D.S., Nie L.N., Fan L., Li Z., Ji W., Hu D.L., Wang D., and Zhou H.H. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients. Eur. J. Clin. Pharmacol. 65 (2009) 679-683
11. Lorenz D., and Deuschl G. Update on pathogenesis and treatment of essential tremor. Curr. Opin. Neurol. 20 (2007) 447-452
12. Louis E.D. Essential tremor. Clin. Geriatr. Med. 22 (2006) 843-857 vii
13. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Kruger R., Rocca W.A., Schneider N.K., Lesnick T.G., Lincoln S.J., Hulihan M.M., Aasly J.O., Ashizawa T., Chartier-Harlin M.C., Checkoway H., Ferrarese C., Hadjigeorgiou G., Hattori N., Kawakami H., Lambert J.C., Lynch T., Mellick G.D., Papapetropoulos S., Parsian A., Quattrone A., Riess O., Tan E.K., and Van Broeckhoven C. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296 (2006) 661-670
14. Pigullo S., Di Maria E., Marchese R., Bellone E., Gulli R., Scaglione C., Battaglia S., Barone P., Martinelli P., Abbruzzese G., Ajmar F., and Mandich P. Essential tremor is not associated with alpha-synuclein gene haplotypes. Mov. Disord. 18 (2003) 823-826
15. Shahed J., and Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat. Disord. 13 (2007) 67-76
16. Shatunov A., Jankovic J., Elble R., Sambuughin N., Singleton A., Hallett M., and Goldfarb L. A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology 65 (2005) 1995 (author reply 1995)
17. Tan E.K., Lee J., Lim H.Q., Yuen Y., and Zhao Y. Essential tremor and the common LRRK2 G2385R variant. Parkinsonism Relat. Disord. 14 (2008) 569-571
18. Tan E.K., Prakash K.M., Fook-Chong S., Yih Y., Chua E., Lum S.Y., Wong M.C., Pavanni R., and Zhao Y. DRD3 variant and risk of essential tremor. Neurology 68 (2007) 790-791
19. Uitti R.J., Baba Y., Wszolek Z.K., and Putzke D.J. Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism Relat. Disord. 11 (2005) 139-145
20. Van Kampen J.M., and Eckman C.B. Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior. J. Neurosci. 26 (2006) 7272-7280
21. Vitale C., Ciotti P., Gulli R., Bellone E., Scaglione C., Abbruzzese G., Martinelli P., Barone P., and Mandich P. Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients. Parkinsonism Relat. Disord. 15 (2009) 162-163